tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Revenue

Compare
349 Followers

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 18.17M in the quarter ending Jun 30, 2025, with -91.40%. This bring the company's revenue in the last twelve months to 232.84M, Decreased 8.44%. In the fiscal year ending Dec 31, 2024, Keros Therapeutics had annual revenue of 3.55M with 2250.99% growth.
Revenue (ttm)
232.84M
Revenue Growth
85820.30%
P/S Ratio
180.20
Revenue/Employee
$21,779
Employees
163
Market Cap
$639.69M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.55M3.40M+2,351.01%
Dec 31, 2023
151.00K-15,100,000.00%
Dec 31, 2022
-20.10M
Dec 31, 2021
20.10M-2,010,000,000.00%
Dec 31, 2020
-10.00M
Dec 31, 2019
10.00M0.00+100.00%
Dec 31, 2018
10.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis